Tri Locum Partners LP Biohaven Pharmaceutical Holding CO Ltd. Transaction History

Tri Locum Partners LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$83.14 - $145.99 $4.3 Million - $7.55 Million	-51,750 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$110.08 - $142.92 $3.02 Million - $3.92 Million	27,404 Added 112.56%	51,750 $6.14 Million
Q4 2021 Feb 14, 2022	BUY	$99.73 - $148.48 $2.43 Million - $3.61 Million	24,346 New	24,346 $3.36 Million
Q1 2021 May 17, 2021	SELL	$64.07 - $91.75 $1.27 Million - $1.82 Million	-19,832 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$65.07 - $98.24 $1.29 Million - $1.95 Million	19,832 New	19,832 $1.7 Million

785K

Ticker BHVN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,645,000
Market Cap $3.65B
Description
Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...

Get notified when there are updates to the investment portfolio of Tri Locum Partners LP, based on Form 13F filings with the SEC.

Stay updated on Tri Locum Partners LP with notifications on news.